❤️ Cardiovascular Health

Health Navigator Workbook

Understanding Your Heart Health

Cardiovascular disease is the #1 killer of women. Standard cholesterol screening misses 80% of true cardiac risk. Advanced testing reveals your true risk — and your prevention strategy.

Cardiovascular Symptoms & Risk Factors

Check any symptoms or risk factors you're experiencing:

Chest discomfort or pressure — especially with exertion, stress, or cold weather

Shortness of breath — with exertion, climbing stairs, or at rest

Heart palpitations — feeling racing or irregular heartbeat

Fatigue or weakness — especially with activity, unexplained

Dizziness or syncope — fainting, lightheadedness, near-fainting episodes

Elevated blood pressure — sustained high readings, poor response to medication

Metabolic risk factors — weight gain, insulin resistance, metabolic syndrome

Family history of heart disease — parent, sibling with early MI or stroke

Menopause transition — loss of estrogen protection increases cardiac risk

Chronic inflammation — autoimmune disease, high inflammatory markers, persistent infections

💡 Women's cardiac truth: 1 in 3 women die of heart disease. Women present differently than men (fatigue, jaw pain, nausea vs chest pain). Early detection saves lives.

Page 1 of 3

❤️ Cardiovascular — Advanced Lab Work

Beyond Standard Cholesterol Testing

The Advanced Lipid & Cardiac Panel

Standard cholesterol (LDL) misses true risk. These advanced markers reveal your true cardiovascular status:

📋 Lipoprotein(a) — Lp(a)
Genetic risk factor. Elevated Lp(a) = high thrombotic risk regardless of LDL. 20-30% of population has elevated Lp(a) — unknown to them.

📋 LDL Particle Size & Number (VAP or Ion Mobility)
Particle size matters more than LDL amount. Small, dense LDL = highly atherogenic. Large, fluffy LDL = protective.

📋 Apolipoprotein B (ApoB)
Better predictor of cardiac risk than LDL. ApoB = number of atherogenic particles circulating.

📋 Apolipoprotein E Genotype (ApoE)
Genetic marker for lipid metabolism & Alzheimer's risk. ApoE4 = lipid sensitivity, higher medication needs.

📋 HDL (Protective) Cholesterol
Low HDL + high triglycerides = metabolic syndrome + cardiac risk. Target HDL >50 mg/dL for women.

📋 Triglycerides (Fasting & Non-fasting)
Elevated triglycerides = insulin resistance, dysbiosis, metabolic dysfunction. Fasting goal <100 mg/dL.

📋 hs-CRP (High-Sensitivity C-Reactive Protein)
Inflammatory marker. Elevated hs-CRP predicts cardiac events independent of cholesterol. Goal <1 mg/L.

📋 Homocysteine (Serum)
Amino acid metabolite. Elevated = vascular damage, thrombosis risk, dementia. Target <8 µmol/L.

📋 Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)
Vascular inflammation marker. Detects coronary inflammation independent of LDL. Goal <200 ng/mL.

📋 Fasting Glucose & Insulin (HOMA-IR)
Insulin resistance drives atherosclerosis. Silent metabolic risk. Fasting glucose <100, fasting insulin <10 µIU/mL.

📋 Thyroid Panel (TSH, Free T3, Free T4)
Thyroid dysfunction increases cardiac risk. Low T3 = metabolic slowing + atherogenesis. Target TSH 0.5-2 mIU/L.

📋 Magnesium & Potassium (Serum + RBC Mag)
Deficiency = arrhythmias, hypertension, vascular spasm. RBC magnesium is more accurate than serum.

Page 2 of 3

❤️ Root Cause Discovery

Investigate Your Cardiac Risk Pattern

Key Questions for Root Cause

1. Family history of early MI or stroke?
Before age 55 in first-degree relative = genetic risk. ApoE genotype + aggressive prevention warranted.

2. Lipid metabolism dysfunction?
Familial hypercholesterolemia? High Lp(a)? Elevated triglycerides? Each requires different strategy.

3. Insulin resistance or metabolic syndrome?
Central weight gain, high triglycerides, low HDL, hypertension, elevated fasting glucose = metabolic driver of atherosclerosis.

4. Chronic inflammation markers?
Elevated hs-CRP, Lp-PLA2? Autoimmune disease? Dysbiosis? Systemic inflammation drives plaque formation.

5. Homocysteine elevation?
Check MTHFR genotype. Elevated homocysteine = methylation dysfunction = vascular damage.

6. Thyroid dysfunction?
Hypothyroidism? Low T3 syndrome? These drive metabolic dysfunction + atherosclerosis.

7. Menopause transition or status?
Estrogen loss accelerates atherosclerosis. Women's cardiac risk rises sharply post-menopause. Bioidentical HRT may be cardioprotective.

8. Gut dysbiosis?
Dysbiosis increases LPS (lipopolysaccharide), drives systemic inflammation + atherosclerosis. Leaky gut = bacterial endotoxin exposure.

Cardiovascular Prevention Strategy

Address insulin resistance — Low glycemic diet, intermittent fasting, strength training, metformin if needed
Anti-inflammatory protocol — Omega-3 (EPA/DHA), curcumin, resveratrol, Mediterranean diet
Magnesium & potassium — Correct deficiency for arrhythmia prevention + blood pressure
Gut healing — Reduce dysbiosis-driven LPS exposure through probiotic + prebiotic protocol
Statin consideration — For high Lp(a) or >7% 10-year risk; discuss risk/benefit with provider
HRT evaluation — Menopause women: bioidentical estradiol + micronized progesterone = cardioprotective if started early
Aspirin? — Only if established CAD. Primary prevention aspirin controversial; discuss with provider.

🔑 Remember: Atherosclerosis takes decades to develop. Advanced testing + early intervention prevents 80% of heart attacks. Your Lp(a) is genetic — but everything else is modifiable.

Page 3 of 3